Replies to post #91451 on Innovation Pharmaceuticals Inc (IPIX)

[TheHound]

Why did the levels even get mentioned in the article? So that a fair picture is painted.

We don't know the answer to your question. We know the levels rose, the lesion disappeared, and she left the trial after the completion of the cohort.

Sorry, I'm still missing where you gave an opinion here. Please enlighten me.

Of course other things can elevate ca 125

That is not what we are talking about!

Instead we are discussing a patient with a known malignancy who has a track record of Ca 125 tests, no doubt many of them, with a rising ca 125 despite Kevetrin. Why did the levels even get mentioned in the article? So that a fair picture is painted.

I am not saying it is a bad drug. No one even knows how well it will even work yet! I am just injecting a note of caution.

For a drug whose dosing has yet to be determined- let alone proving that the drug actually works in a real clinical trial- caution is essential. Dr Menon, who has no doubt seen MANY promising drugs fail in clinical trials, would tell you the same.

I have explained who I am and why I started reading up on CTIX. I am neither a basher nor a short. I am just as interested in you as seeing the clinical trial results, and agree that the stock has amazing potential. I would think there would be more tolerance of other opinions.[\quote]

[TheDane]

I just love this discussion of CA-125! So enlightening and useful! And so many posts dedicated to it. I'm sure this will help shareholders make informed decisions about CTIX,


:-D

Go CTIX,

[frrol]

p53 put anyone who bashes you on ignore if they don't let up. It's the only way to deal with such silliness.